Neurocrine Biosciences, Inc. Common Stock (NASDAQ: NBIX) last traded at $152.57, down 0.24% on the session. The quote above updates while this page is open; the figures below are drawn from Neurocrine Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Neurocrine Biosciences, Inc. Common Stock trades on NASDAQ under the ticker NBIX. Its market capitalisation is $15.51 billion.
Valuation measures for Neurocrine Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $15.51B |
|---|---|
| Enterprise value | $16.84B |
| P/E ratio | 22.34 |
| Price / sales | 4.60 |
| Price / book | 4.20 |
| Beta | 0.65 |
Trailing-twelve-month figures tagged in Neurocrine Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.37B |
|---|---|
| Net income (TTM) | $705.50M |
| EPS (TTM) | $6.83 |
| Operating margin | 23.56% |
| Return on equity | 19.10% |
| Cash | $332.40M |
Range and volume for NBIX over the past 52 weeks.
| 52-week high | $186.12 |
|---|---|
| 52-week low | $122.14 |
| Volume | 1.23M |
| Average volume | 1.26M |
| Previous close | $152.93 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.